Metabolism in cancer patients

Anticancer Research

Volumn 30, Issue 5, 2010, Pages 1863-1868

  Arends, Jann ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cancer; Energy metabolism; Malnutrition; Metabolic syndrome X; Obesity; Palliative care; Primary prevention; Review; Tertiary prevention

Indexed keywords

DEOXYGLUCOSE; DOXORUBICIN; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR; PROTEIN KINASE B;

BODY COMPOSITION; BODY WEIGHT; BREAST CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RECURRENCE; CELL PROLIFERATION; COLON CANCER; CONFERENCE PAPER; DIETARY INTAKE; DISEASE COURSE; GOOD CLINICAL PRACTICE; HUMAN; INSULIN RESISTANCE; MALNUTRITION; METABOLISM; NUTRITIONAL COUNSELING; NUTRITIONAL SUPPORT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TERMINAL CARE; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; ENERGY METABOLISM; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALNUTRITION; MEDICAL ONCOLOGY; METABOLIC SYNDROME X; NEOPLASMS; NUTRITIONAL SCIENCES; OBESITY;

EID: 77954618219     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (91)

1. Robert Koch Institute: Cancer in Germany 2005/2006. Incidence and Trends. Berlin, 2010.
2. Rachet B, Woods LM, Mitry E, Riga M, Cooper N, Quinn MJ, Steward J, Brenner H, Estève J, Sullivan R and Coleman MP: Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 99: S2-S10, 2008.
3. American Cancer Society: Cancer facts and figures 2009. Atlanta, Georgia, USA, 2009.
4. Garcia M, Jemal A, Ward E, Center M, Hao Y, Siegel R and Thun M: Global Cancer: Facts and Figures 2007. Atlanta, Georgia, USA 2007.
5. Ramanathan A, Wang C and Schreiber SL: Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci USA 102: 5992-5997, 2005. (Pubitemid 40594243)
6. Demetrius LA, Coy JF and Tuszynski JA: Cancer proliferation and therapy: the Warburg effect and quantum metabolism. Theor Biol Med Model 7: 2, 2010.
7. Tennant DA, Durán RV and Gottlieb E: Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 10: 267-277, 2010.
8. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
9. Deans C and Wigmore SJ: Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8: 265-269, 2005. (Pubitemid 40586184)
10. Ewing J: Pathological aspects of some problems of experimental cancer research. J Cancer Res 1: 71-86, 1916.
11. Müller-Hübenthal B, Azemar M, Lorenzen D, Huber M, Freudenberg MA, Galanos C, Unger C and Hildenbrand B: Tumour Biology: tumour-associated inflammation versus antitumor immunity. Anticancer Res 29: 4795-4805, 2009.
12. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
13. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
14. Cassileth BR, Deng GE, Gomez JE, Johnstone PAS, Kumar N and Vickers AJ: Complementary therapies and integrative oncology in lung cancer: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest 132: 340S-354S, 2007. (Pubitemid 47494412)
15. Deng GE, Cassileth BR, Cohen L, Gubili J, Johnstone PAS, Kumar N, Vickers A, Abrams D, Rosenthal D, Sagar S and Tripathy D: Integrative oncology practice guidelines. J Soc Integr Oncol 5: 65-84, 2007.
16. Hirai K, Komura K, Tokoro A, Kuromaru T, Ohshima A, Ito T, Sumiyoshi Y and Hyodo I: Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) in cancer patients. Ann Oncol 19: 49-55, 2008.
17. Nahleh Z and Tabbara IA: Complementary and alternative medicine in breast cancer patients. Palliat Support Care 1: 267-273, 2003.
18. Vickers AJ: Which botanicals or other unconventional anticancer agents should we take to clinical trial? J Soc Integr Oncol 5: 125-129, 2007.
19. Weitzman S: Complementary and alternative (CAM) dietary therapies for cancer. Pediatr Blood Cancer 50: 494-497, 2008.
20. Hardy ML: Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin North Am 22: 581-617, 2008.
21. Hsu IR, Kim SP, Kabir M and Bergman RN: Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 86: S867-871, 2007.
22. Rose DP, Haffner SM and Baillargeon J: Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev 28: 763-777, 2007.
23. Prado CMM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, Butts CA, Scarfe AG and Sawyer MB: Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 13: 3264-3268, 2007. (Pubitemid 46944911)
24. Skipworth RJE, Stewart GD, Dejong CHC, Preston T and Fearon KCH: Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clin Nutr 26: 667-676, 2007.
25. McMillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12: 223-226, 2009.
26. Glade MJ: Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 15: 523-526, 1999.
27. Pischon T, Schulz M and Boeing H: The role of nutrition in the primary prevention of malignant tumors: epidemiological evidence. Aktuel Ernaehr Med 32: 31-40, 2007.
28. Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. Washington, DC, USA: American Institute for Cancer Research, 2007.
29. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003. (Pubitemid 36459468)
30. Barone BB, Yeh H, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC and Brancati FL: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300: 2754-2764, 2008.
31. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M and Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202, 2005. (Pubitemid 40095870)
32. Yang Y, Hennessy S and Lewis JD: Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127: 1044-1050, 2004. (Pubitemid 39345873)
33. Giovannucci E: Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86: s836-s842, 2007.
34. Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Tjønneland A, Olsen A, Overvad K, Jakobsen MU, Chajès V, Clavel-Chapelon F, Boutron-Ruault M, Linseisen J, Lukanova A, Boeing H, Pischon T, Trichopoulou A, Christina B, Trichopoulos D, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Gram IT, Lund E, Quiros JR, Travier N, Martinez-García C, Larrañaga N, Chirlaque M, Ardanaz E, Berglund G, Lundin E, Bueno-de-Mesquita HB, van Duijnhoven FJB, Peeters PHM, Bingham S, Khaw K, Allen N, Key T, Ferrari P, Rinaldi S, Slimani N and Riboli E: Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14: 755-767, 2007.
35. Pais R, Silaghi H, Silaghi A, Rusu M and Dumitrascu D: Metabolic syndrome and risk of subsequent colorectal cancer. World J. Gastroenterol 15: 5141-5148, 2009.
36. Laukkanen JA, Laaksonen DE, Niskanen L, Pukkala E, Hakkarainen A and Salonen JT: Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol. Biomarkers Prev 13: 1646-1650, 2004.
37. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD and Folsom AR: The metabolic syndrome and risk of incident colorectal cancer. Cancer 107: 28-36, 2006. (Pubitemid 43941640)
38. Cowey S and Hardy RW: The metabolic syndrome: A high-risk state for cancer? Am J Pathol 169: 1505-1522, 2006.
39. Sinagra D, Amato C, Scarpilta AM, Brigandì M, Amato M, Saura G, Latteri MA and Caimi G: Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci 6: 55-59, 2002. (Pubitemid 36395320)
40. Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, Neuhouser ML, Parker DR, Shikany JM, Stefanick ML, Thomson CA and Rohan TE: A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol. Biomarkers Prev 18: 2046-2053, 2009.
41. Lee JS, Cho S and Park HS: Metabolic syndrome and cancer-related mortality among Korean men and women. Ann Oncol 21: 640-645, 2010.
42. Andreyev HJ, Norman AR, Oates J and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34: 503-509, 1998.
43. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MAE, von Meyenfeldt M, Zürcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ and Zander A: ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr 25: 245-259, 2006.
44. Vaisman N, Stallings VA, Chan H, Weitzman SS, Clarke R and Pencharz PB: Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Am J Clin Nutr 57: 679-684, 1993.
45. Melville S, McNurlan MA, Calder AG and Garlick PJ: Increased protein turnover despite normal energy metabolism and responses to feeding in patients with lung cancer. Cancer Res 50: 1125-1131, 1990. (Pubitemid 20083998)
46. Kibirige MS, Morris Jones PH, Stevens RF and Rennie MJ: Reduced leucine catabolism induced by chemotherapy in leukemic children. Pediatr Hematol Oncol 6: 11-16, 1989.
47. de Koning BA, van der Schoor SR, Wattimena DL, de Laat PC, Pieters R and van Goudoever JB: Chemotherapy does not influence intestinal amino acid uptake in children. Pediatr Res 62: 195-199, 2007. (Pubitemid 47205722)
48. Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P, Jauch KW, Kernen M, Hiesmayr JM, Horbach T, Kuse ER and Vestweber KH: ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 25: 224-244, 2006.
49. Ravasco P, Monteiro-Grillo I, Vidal PM and Camilo ME: Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23: 1431-1438, 2005. (Pubitemid 46260030)
50. Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G and Muscaritoli M: ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr 28: 445-454, 2009.
51. Lundholm K, Daneryd P, Bosaeus I, Körner U and Lindholm E: Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function. Cancer 100: 1967-1977, 2004.
52. Holmes MD, Chen WY, Feskanich D, Kroenke CH and Colditz GA: Physical activity and survival after breast cancer diagnosis. JAMA 293: 2479-2486, 2005. (Pubitemid 40705729)
53. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B and Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20: 42-51, 2002. (Pubitemid 34032594)
54. Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL and Fuchs CS: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24: 3535-3541, 2006.
55. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML and Abbruzzese JL: Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301: 2553-2562, 2009.
56. Chlebowski RT, Aiello E and McTiernan A: Weight loss in breast cancer patient management. J Clin Oncol 20: 1128-1143, 2002. (Pubitemid 34141858)
57. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR and Kane CJ: Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology 66: 1060-1065, 2005. (Pubitemid 41587161)
58. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL and Elashoff RM: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 98: 1767-1776, 2006.
59. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA and Fuchs CS: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 24: 3527-3534, 2006. (Pubitemid 46630522)
60. Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, Parker BA, Newman VA, Caan B and Rock CL: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 25: 2345-2351, 2007.
61. Hippocrates of Kos: Aphorism XXXV. In: The Aphorisms of Hippocrates. London: Longman and Co. p. 34, 1822.
62. Costa G and Donaldson SS: Current concepts in cancer: effects of cancer and cancer treatment on the nutrition of the host. N Engl J Med 300: 1471-1474, 1979.
63. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW and Tormey DC: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491-497, 1980.
64. Shizgal HM: The effect of malnutrition on body composition. Surg Gynecol Obstet 152: 22-26, 1981.
65. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 2: 862-871, 2002.
66. Good RA, West A, Day NK, Dong ZW and Fernandes G: Effects of undernutrition of host cell and organ function. Cancer Res 42: 737s-746s, 1982. (Pubitemid 12159247)
67. Klastersky J, Daneau D and Verhest A: Causes of death in patients with cancer. Eur J Cancer 8: 149-154, 1972.
68. Ambrus JL, Ambrus CM, Mink IB and Pickren JW: Causes of death in cancer patients. J Med 6: 61-64, 1975.
69. Inagaki J, Rodriguez V and Bodey GP: Proceedings: Causes of death in cancer patients. Cancer 33: 568-573, 1974.
70. Van Cutsem E and Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9(Suppl 2): S51-S63, 2005.
71. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG and Lowry SF: A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037, 2005.
72. Cahill GF: Fuel metabolism in starvation. Annu Rev Nutr 26: 1-22, 2006.
73. Körber J, Pricelius S, Heidrich M and Müller MJ: Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr 53: 740-745, 1999.
74. Canada T: Clinical dilemma in cancer: is tumor growth during nutrition support significant? Nutr Clin Pract 17: 246-248, 2002.
75. Bozzetti F, Gavazzi C, Mariani L and Crippa F: Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours. Clin Nutr 23: 417-421, 2004. (Pubitemid 38811680)
76. Holm E, Hagmüller E, Staedt U, Schlickeiser G, Günther HJ, Leweling H, Tokus M and Kollmar HB: Substrate balances across colonic carcinomas in humans. Cancer Res 55: 1373-1378, 1995.
77. Warburg O, Posener K and Negelein E: Über den Stoffwechsel der Carzinomzelle Biochemische Zeitschrift. Biochemische Z 152: 309-344, 1924.
78. Warburg OH: Ideen zur Fermentchemie der Tumoren. Berlin: Akademie-Verl.; 1947.
79. Flier JS, Mueckler MM, Usher P and Lodish HF: Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235: 1492-1495, 1987. (Pubitemid 17038084)
80. Brand KA and Hermfisse U: Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 11: 388-395, 1997.
81. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
82. Esteban MA and Maxwell PH: HIF, a missing link between metabolism and cancer. Nat Med 11: 1047-1048, 2005.
83. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and Thompson CB: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892-3899, 2004.
84. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR and Lampidis TJ: 2-Deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 64: 31-34, 2004.
85. Coy JF, Dressier D, Wilde J and Schubert P: Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 51: 257-273, 2005.
86. Pelicano H, Martin DS, Xu R and Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646, 2006.
87. Zadra G, Priolo C, Patnaik A and Loda M: New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK [Internet]. Clin Cancer Res 2010; available from: http://www.ncbi.nlm.nih.gov/pubmed/20423984
88. Wysocki PJ and Wierusz-Wysocka B: Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Expert Rev Mol Diagn 10: 509-519, 2010.
89. Haber RS, Weiser KR, Pritsker A, Reder I and Burstein DE: GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7: 363-367, 1997. (Pubitemid 27295132)
90. Burstein DE, Reder I, Weiser K, Tong T, Pritsker A and Haber RS: GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions. Mod Pathol 11: 392-396, 1998. (Pubitemid 28208103)
91. Noguchi Y, Marat D, Saito A, Yoshikawa T, Doi C, Fukuzawa K, Tsuburaya A, Satoh S and Ito T: Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology 46: 2683-2689, 1999. (Pubitemid 29454167)